Risk and protective factors for leprosy development determined by epidemiological surveillance of household contacts

Clinical and Vaccine Immunology

Volumn 15, Issue 1, 2008, Pages 101-105

  Goulart, Isabela M B ^a   Bernardes Souza, Dulcinéa O ^a   Marques, Carolina R ^a   Pimenta, Vânia L ^a   Gonçalves, Maria A ^a   Goulart, Luiz R ^a  

^a FEDERAL UNIVERSITY OF UBERLÂNDIA   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; BACTERIAL ANTIGEN; GLYCOLIPID; PHENOLIC GLYCOLIPID I, MYCOBACTERIUM LEPRAE;

ARTICLE; BCG VACCINATION; CONTROLLED STUDY; DISEASE TRANSMISSION; HOUSEHOLD; HUMAN; HUMORAL IMMUNITY; LEPROMIN TEST; LEPROSY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RISK FACTOR; BLOOD; BRAZIL; ENDEMIC DISEASE; FAMILY SIZE; IMMUNOLOGY; INCIDENCE; ISOLATION AND PURIFICATION; MICROBIOLOGY; MYCOBACTERIUM LEPRAE;

ANTIGENS, BACTERIAL; BCG VACCINE; BRAZIL; ENDEMIC DISEASES; FAMILY CHARACTERISTICS; GLYCOLIPIDS; HUMANS; INCIDENCE; LEPROSY; MYCOBACTERIUM LEPRAE; RISK FACTORS;

EID: 43149095378     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00372-07     Document Type: Article

References (28)

1. Araoz, R., N. Honore, S. Cho, J. P. Kim, S. N. Cho, M. Monot, C. Demangel, P. J. Brennan, and S. T. Cole. 2006. Antigen discovery: a postgenomic approach to leprosy diagnosis. Infect. Immun. 74:175-182.
2. Bechelli, L. M., P. G. Garbajosa, M. M. Gyi, K. Uemura, T. Sundaresan, V. D. Martinez, M. Matejka, C. Tamondong, R. Quagliato, V. Engler, and M. Altmann. 1973. BCG vaccination of children against leprosy: seven-year findings of the controlled WHO trial in Burma. Bull. W. H. O. 48:323-334.
3. Bechelli, L. M., K. Lwin, P. G. Garbajosa, M. G. Gyi, K. Uemura, T. Sundaresan, C. Tamondong, M. Matejka, H. Sansarricq, and J. Walter. 1974. BCG vaccination of children against leprosy: nine-year findings of the controlled WHO trial in Burma. Bull. W. H. O. 51:93-99.
4. Brasil Ministério da Saúde. 2002. Guia para o controle da hanseníase. Cadernos de atenção básica, no. 10. Ministério de Saúde, Brasilia, DF, Brazil.
5. Bührer-Sékula, S., H. L. Smits, G. C. Gussenhoven, J. van Leeuwen, S. Amador, T. Fujiwara, P. R. Klatzer, and L. Oskam. 2003. Simple and fast lateral flow test for classification of leprosy patients and identification of contacts with high risk of developing leprosy. J. Clin. Microbiol. 41:1991-1995.
6. Convit, J., C. Sampson, M. Zuniga, P. G. Smith, J. Plata, J. Silva, J. Molina, M. E. Pinardi, B. R. Bloom, and A. Salgado. 1992. Immunoprophylactic trial with combined Mycobacterium leprae/BCG vaccine against leprosy: preliminary results. Lancet 339:446-450.
7. Convit, J., P. G. Smiths, M. Zuniga, C. Sampson, M. Ulrich, J. A. Plata, J. Silva, J. Molina, and A. Salgado. 1993. BCG vaccination protects against leprosy in Venezuela: a case-control study. Int. J. Lepr. Other Mycobact. Dis. 62:185-191.
8. Cunaman, A., Jr., G. P. Chan, and J. T. Douglas. 1998. Risk of development of leprosy among Culion contacts. Int. J. Lepr. Other Mycobact. Dis. 66:S78A.
9. Doull, J. A., R. S. Guinto, J. N. Rodriguez, and H. Bancroft. 1942. The incidence of leprosy in Cordova and Talisay. Cebu, Philippines. Int. J. Lepr. 10:107-131.
10. Doull, J. A., R. S. Guinto, and M. C. Mabalay. 1957. Effect of BCG vaccination, lepromin testing and natural causes in inducing reactivity to lepromin and to tuberculin. Int. J. Lepr. 25:13-37.
11. Fernandes, J. M. M. 1939. Estudio comparativo de la reaccion de Mitsuda con las reacciones tuberculinicas. Rev. Arg. Dermat. 23:425-452.
12. Fine, P. E., J. A. Sterne, J. M. Ponninghaus, L. Bliss, J. Saul, A. Chihana, M. Munthali, and D. K. Warndorff. 1997. Household and dwelling contact as risk factors for leprosy in northern Malawi. Am. J. Epidemiol. 146:91-102.
13. Harboe, M. 1985. The immunology of leprosy, p. 53-87. In R. C. Hastings (ed.), Leprosy. Churchill Livingstone, Edinburgh, United Kingdom.
14. International Leprosy Association. 2002. Report of the International Leprosy Association Technical Forum. Int. J. Lepr. Other Mycobact. Dis. 70(Suppl. 1):S23-S31.
15. Lwin, K., T. Sundaresan, M. M. Gyi, L. M. Bechelli, C. Tamondong, P. G. Gallego, H. Sansarricq, and S. K. Noordeen. 1985. BCG vaccination of children against leprosy: fourteen-year findings of the trial in Burma. Bull. W. H. O. 63:1069-1078.
16. Michalany, J., N. S. Michalany, and V. Petri. 1983. The Mitsuda reaction and its antigen, good subjects for a bibliography. Hansenol. Int. 8:140-147.
17. Muliyil, J., K. E. Nelson, and E. L. Diamond. 1991. Effect of BCG on the risk of leprosy in an endemic area: a case-control study. Int. J. Lepr. Other Mycobact. Dis. 59:229-236.
18. Nordeen, S. K. 1999. Plenary session on the needs and opportunities for prevention of leprosy: discussion, conclusions and recommendations. Int. J. Lepr. 67:72-80.
19. Pönnighaus, J. M., P. E. Fine, J. A. Sterne, R. J. Wilson, E. Msosa, P. J. Gruer, P. A. Jenkins, S. B. Lucas, N. G. Liomba, and L. Bliss. 1992. Efficacy of BCG vaccine against leprosy and tuberculosis in Northern Malawi. Lancet 339:636-639.
20. Reece, S. T., G. Ireton, R. Mohamath, J. Guderian, W. Goto, R. Gelber, N. Groathouse, J. Spencer, P. Brennan, and S. G. Reed. 2006. ML0405 and ML2331 are antigens of Mycobacterium leprae with potential for diagnosis of leprosy. Clin. Vaccine Immunol. 13:333-340.
21. Setia, M. S., C. Steinmaus, C. S. Ho, and G. W. Rutherford. 2006. The role of BCG in prevention of leprosy: a meta-analysis. Lancet Infect. Dis. 6:162-170.
22. Spencer, J. S., H. M. Dockrell, H. J. Kim, M. A. Marques, D. L. Williams, M. V. Martins, M. L. Martins, M. C. Lima, E. N. Sarno, G. M. Pereira, H. Matos, L. S. Fonseca, E. P. Sampaio, T. H. Ottenhoff, A. Geluk, S. N. Cho, N. G. Stoker, S. T. Cole, P. J. Brennan, and M. C. Pessolani. 2005. Identification of specific proteins and peptides in Mycobacterium leprae suitable for the selective diagnosis of leprosy. J. Immunol. 175:7930-7938.
23. Spencer, J. S., H. J. Kim, M. A. Marques, M. Gonzalez-Juarerro, M. C. Lima, V. D. Vissa, R. W. Truman, M. L. Gennaro, S. N. Cho, S. T. Cole, and P. J. Brennan. 2004. Comparative analysis of B- and T-cell epitopes of Mycobacterium leprae and Mycobacterium tuberculosis culture filtrate protein 10. Infect. Immun. 72:3161-3170.
24. Van Beers, S., M. Hatta, and P. R. Klatser. 1999. Seroprevalence rates of antibodies to phenolic glycolipid-I among school children as an indicator of leprosy endemicity. Int. J. Lepr. 67:243-249.
25. WHO. 1953. WHO technical report series, no. 71. WHO Expert Committee on Leprosy. WHO, Geneva, Switzerland.
26. WHO. 2000. Guide to eliminate leprosy as a public health problem, 1st ed. World Health Organization Expert Committee on Leprosy, Geneva, Switzerland.
27. Yanagisawa, K. 1960. On the immunological relationship between tuberculosis and leprosy with special reference to the effect of BCG administration upon the prophylaxis of leprosy. La Lepro. 26-28:37-47.
28. Zodpey, S. P. 2007. Protective effect of bacillus Calmet Guérin (BCG) vaccine in the prevention of leprosy: a meta-analysis. Ind. J. Dermatol. Venereol. Leprol. 73:86-93.